PosPhentap Cheopbuje (Pelvinac)

Adult dosage

S-Type: After removing the peeling agent from the adhesive side, apply 1 sheet to the affected area twice a day. R-Type: Cut to an appropriate length, remove the peeling agent from the adhesive side, and apply to the affected area twice a day.

This medication should not be used by patients who have had allergic reactions to this medication or its components, or to other Felbinac formulations. Additionally, patients with a history of asthma attacks when using aspirin or other non-steroidal anti-inflammatory drugs should not use this medication, as it may induce asthma attacks. Patients who have experienced hives or acute rhinitis from aspirin or non-steroidal anti-inflammatory drugs should also avoid using this medication. Caution is advised for patients with bronchial asthma, as this medication may trigger asthma attacks. This medication may cause itching, skin redness, erythema, dermatitis, contact dermatitis, and in rare cases, irritation or blisters. If these symptoms worsen, use should be discontinued immediately. Furthermore, rare but severe allergic reactions accompanied by hives or bronchospasm may occur, so caution is necessary. This medication can also cause gastrointestinal disturbances. It is a symptomatic treatment for alleviating inflammation or pain and does not treat the underlying causes, which should be understood. When used in areas with skin infections, it may exacerbate the infection, so it should be used with antibacterial or antifungal agents while monitoring the condition closely. When using for chronic conditions like degenerative arthritis, other treatment options should be considered alongside medication treatment, and the patient's condition and potential side effects should be carefully monitored. In late pregnancy, this medication may cause adverse labor or delayed childbirth, so it should not be used by pregnant women, women who may become pregnant, or nursing mothers. Safety has not been established for children, so it is not recommended for use in pediatric patients. Do not apply to damaged skin, mucous membranes, or areas with eczema or rash, and take care to avoid contact with eyes or mucous membranes. Caution is needed as temporary irritation or tingling may occur when applied to damaged skin. Additionally, this medication should not be used with occlusive dressings.

Serious side effects

Widespread rash accompanied by hives and bronchospasm, asthma attacks.

Mild side effects

• Itching
• redness
• erythema
• dermatitis (rash, eczema)
• contact dermatitis
• irritation
• blisters
• paresthesia
• gastrointestinal disturbances.

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1°C and 30°C at room temperature. This will help to maintain the effectiveness of the medication and prevent deterioration.

Appearance

S-type I: A colorless, transparent, adhesive substance applied to apricot-colored lint cloth, covering the solid surface with a peeling agent. S-type II: A colorless, transparent, adhesive substance applied to red lint cloth, covering the solid surface with a peeling agent.

Package unit

10 sheets/package